PlainRecalls
FDA Drug Moderate Class II Ongoing

Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA, NDC 63629-1067-01

Reported: March 24, 2021 Initiated: January 27, 2021 #D-0304-2021

Product Description

Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA, NDC 63629-1067-01

Reason for Recall

Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.

Details

Units Affected
12 bottles
Distribution
Nationwide in the USA
Location
Burbank, CA

Frequently Asked Questions

What product was recalled?
Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA, NDC 63629-1067-01. Recalled by Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals. Units affected: 12 bottles.
Why was this product recalled?
Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 24, 2021. Severity: Moderate. Recall number: D-0304-2021.